Pricing Log in Create free account
Saturday 17 October 2026 Export GEHC’s income statement to Excel — free account

GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.

69.57 0.78 −1.11%
Market cap
$31.8B
P/E
16.0×
Fwd P/E
14.4×
Dividend yield
0.26%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

GE HealthCare Technologies Inc. (GEHC) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, GE HealthCare Technologies Inc. (GEHC) trades at a price to free cash flow of 20.0×. Over the past ten years it has ranged from 13.9× (January 2023) to 36.0× (December 2022); the current reading is higher than 29% of that period. That is below the Medical Devices industry median of 23.7× and in line with the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 24.9× 8.33%
FY2024 22.9× 13.22%
FY2023 20.3× 45.68%
FY2022 13.9× (61.40%)
FY2021 36.0× 0.00%
FY2020 36.0× 0.00%
FY2019 36.0× —

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 18.4× (14.06%)
Mar 2026 21.4× (14.02%)
Dec 2025 24.9× 1.59%
Sep 2025 24.5× 13.38%
14 more quarters

Against its own ten years

Low 13.9× High 36.0×
Ten-year median 21.6×
Current reading's percentile 29

Price to free cash flow against peers

Company Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare 6.4×
PHG Koninklijke Philips N.V. compare 13.3×
ZBH Zimmer Biomet Holdings, Inc. compare 17.6×
BSX Boston Scientific Corporation compare 18.0×
GEHC GE HealthCare Technologies Inc. 20.0×
STE STERIS plc compare 23.2×
DXCM DexCom, Inc. compare 23.4×
EW Edwards Lifesciences Corporation compare 35.6×
PEN Penumbra, Inc. compare 58.5×
Medical Devices industry median 23.7×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on GEHC